FilingSEC EDGAR6-K
Alterity Therapeutics Reports Corporate Governance Compliance
· SEC accepted
StageReporting
Filing content
The company submitted its Appendix 4G detailing its compliance with the Corporate Governance Council Principles and Recommendations of the ASX.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…